Different dosage regimens of Eptinezumab for the treatment of migraine: a meta-analysis from randomized controlled trials.
Zeya YanTao XueShujun ChenXin WuXingyu YangGuangjie LiuShan GaoZhouqing ChenZhong WangPublished in: The journal of headache and pain (2021)
In the present study, we found that eptinezumab is safe and has significant efficacy in the treatment of migraine, especially the dose of 300 mg.